Navigation Links
Blitzkrieg Declared On American Medicine
Date:12/10/2008

TUCSON, Ariz., Dec. 10 /PRNewswire-USNewswire/ -- The incoming administration and Democratic Congress are determined to complete the job started around 1900 and last attempted by Clinton in 1993: the nationalization of American medicine. They plan to move fast, seize momentum, and not let go.

"We need to be on the offense," said former South Dakota Senator Tom Daschle, presumptive new Secretary of Health and Human Services.

The bill might well be S. 1, and Senator Ted Kennedy (D-MA) may seek support for this as his final Act before he departs the Senate. Obama is expected to go along with it, despite some initial differences, and might sign it shortly after Inauguration.

This bill will favor the insurance industry even more than Clinton Care did, perhaps because Kennedy and Obama fear a repeat of the Harry and Louise television ads that helped sink the Clinton plan. Insurance companies are getting a gold mine this time in return for their support: everyone will be forced to buy a government-approved plan, however overpriced and undesirable it is. Subsidies to select groups will buy off opposition.

Because insurers will be forced to take all comers and charge them all the same, younger and healthier people will be greatly overcharged to subsidize those who are older and sicker. Since the charge will not be based on risk, it may be called a "premium," but it will actually be a privatized tax: a neat way to circumvent resistance to tax increases, while pouring more money into the system. Long waiting lists for seeing your doctor will develop because healthy people seeking their money's worth will crowd out those who really need the care.

From Clinton's failure in 1994, Obama has learned not to propose a 1,500-page bill, full of details that can be targeted. Instead, he wants broad principles, with details to be filled in later, possibly by Daschle's "Health Care
'/>"/>

SOURCE Association of American Physicians and Surgeons (AAPS)
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. 30 Years After State of Emergency Declared at Love Canal, NY Closing the 99th Street School Triggering the Federal Superfund Program; Schools & Communities Across the Nation Still at Risk of Toxic Contamination
2. Leiner Health Products Issues Allergy Alert on Undeclared Allergens in Liquimax(R) Multivitamin
3. Allergy Alert on Undeclared Soy Ingredient in Bulk Cases of GFS Ultra-Pasteurized Non-Dairy Creamer
4. CATalyst Summit Declared a Success: Its All About the Cat!
5. RxElite Registration Statement Declared Effective by Securities and Exchange Commission
6. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
7. P.A.C.K. Week Declared in Support of Fruits & Veggies-More Matters Month
8. Melanoma Foundation of New England Wins Gold Triangle Award From the American Academy of Dermatology
9. American Lung Association Announces Support of Pickens Plan
10. Fewer HIV-Infected Americans Passing the Virus On
11. Eisai Inc. and the North American Thrombosis Forum (NATF)* Introduce the DVTeamCare(TM) Hospital Award and Call for Nominations
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Beverage Can Stay Tabs Pose Swallowing Risk 62223 1Beverage Can Stay Tabs Pose Swallowing Risk 62223 2New Class of Platinum Based Anti Tumor Drugs Bisplatinates Demonstrates Potent Anti Tumor Activity and Ability to Overcome Resistance to Currently A 14993 1New Class of Platinum Based Anti Tumor Drugs Bisplatinates Demonstrates Potent Anti Tumor Activity and Ability to Overcome Resistance to Currently A 14993 2New Class of Platinum Based Anti Tumor Drugs Bisplatinates Demonstrates Potent Anti Tumor Activity and Ability to Overcome Resistance to Currently A 14993 3Elsevier is Re Launching 26quot 3BEmbase 26quot 3B to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 14989 1Elsevier is Re Launching 26quot 3BEmbase 26quot 3B to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 14989 2Elsevier is Re Launching 26quot 3BEmbase 26quot 3B to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 14989 3